Thrombomodulin mutations in atypical hemolytic-uremic syndrome. - Wikidata - awgldk - TriplyDB

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

http://www.wikidata.org/entity/Q33385474

about

Atypical hemolytic uremic syndrome Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome Hemolytic uremic syndrome: new developments in pathogenesis and treatment Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype Pathophysiology of thrombotic thrombocytopenic purpura Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome Advances and challenges in the management of complement-mediated thrombotic microangiopathies Hemolytic uremic syndrome Protein C anticoagulant and cytoprotective pathways Current treatment of atypical hemolytic uremic syndrome Atypical hemolytic-uremic syndrome: a case report and literature review PAMPs and DAMPs as triggers for DIC ADAMTS13 and von Willebrand factor in thrombotic thrombocytopenic purpura Haemolytic uraemic syndrome.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Excessive activation of the complement system in atypical hemolytic uremic syndrome: is it ready for prime time?Myocardial infarction is a complication of factor H-associated atypical HUS.Complement inhibition decreases the procoagulant response and confers organ protection in a baboon model of Escherichia coli sepsis.Genetics and complement in atypical HUS.Triggering of atypical hemolytic uremic syndrome by influenza A (H1N1).aHUS caused by complement dysregulation: new therapies on the horizon.The role of endothelial cell injury in thrombotic microangiopathy.Advances in our understanding of the pathogenesis of glomerular thrombotic microangiopathy.Eculizumab induces long-term remission in recurrent post-transplant HUS associated with C3 gene mutation.Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?Manifestation of atypical hemolytic uremic syndrome caused by novel mutations in MCP.Complement activation during liver transplantation-special emphasis on patients with atypical hemolytic uremic syndrome.Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome Age-related penetrance of hereditary atypical hemolytic uremic syndrome.Common genetic variants in complement genes other than CFH, CD46 and the CFHRs are not associated with aHUS.Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics Endothelial cells and thrombotic microangiopathy.Atypical hemolytic uremic syndrome and genetic aberrations in the complement factor H-related 5 gene Novel C3 mutation p.Lys65Gln in aHUS affects complement factor H binding.Thrombotic microangiopathy and associated renal disorders.Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies.Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.STEC-HUS, atypical HUS and TTP are all diseases of complement activation.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.

P2860

Q21202864-A42EFDB2-CCF6-448A-ADFC-C90CA28B076F Q24606843-B51AD497-9DF8-41EA-AF29-A545024A3BE1 Q24613517-CE4ED74A-9A82-456B-9C0A-8868E8E7C59B Q24613907-C2034F50-6D75-4B59-A906-BF2797F5C0B6 Q24614117-3954D2CE-8711-452F-B9EC-76E23F9AAA4A Q24622189-77C375B8-90B8-40A1-A5F2-F2DA7F11444B Q26796453-0540B8B9-21EC-4306-9476-5AC62BAA011B Q26799054-59E07739-143F-41E8-86F7-163C81E11801 Q26999113-BE91EB1F-30AB-49DC-BFEB-B53AE3D39900 Q27003211-EAD13093-44E7-4B4B-9615-ADC19EA0B1B8 Q27003863-8033DFE5-716F-400A-A621-08A79C552CAA Q27013790-8279FA14-2D18-4CBD-891B-91F933BAD3D7 Q28083264-AEFC6CC3-C3C0-4734-BAB9-31B7D3EF3BE3 Q30244707-E4710A19-0A04-469D-8B97-4270D397D2BA Q30276550-5B9B3C65-368C-4816-A60E-849D55EA9195 Q33388046-32902C54-65CB-4A94-AB99-DB813A7ECA35 Q33388820-0EE5DA2C-BD1D-4CB6-917C-4F5B7BEB822B Q33389544-AC892B3A-2FC8-4BFA-A53D-DFE7F09E0395 Q33389945-B4768A13-9C70-4ED8-9F42-27576F95199E Q33390080-14721E85-D295-450A-8E30-643AF71830FD Q33390198-B0EB2417-1CFD-49E6-B771-934DCA9737B3 Q33391882-C1B7F456-45A3-4692-A085-D7A190A4AC96 Q33392316-0D526F73-8F04-489C-A2EF-6B1A0FE06C6B Q33393107-8371A773-9E5F-483F-955E-5B0360C662C5 Q33395774-61024C76-6FE5-4A05-833B-DAB68C1D23D7 Q33395944-B9EC4EA4-BD80-481B-B189-F8FD8C6343AE Q33396528-16F41A8A-887E-482E-95AC-7AF52A6D05B1 Q33396792-E7F65E27-4DE9-49B4-A76F-6A6347460BDF Q33397115-2172E893-4E4C-4D1D-A0EB-89A7EF0C976B Q33398635-E77CE09B-3EB0-4C3F-9EF5-0237F88F1C51 Q33400211-8CB9F5D7-C4B2-4914-9FF0-413A3BC6E1B7 Q33401369-60B8D42E-AD7D-4656-BDE6-968A9A63F3BB Q33401386-AE94B4C1-D0C3-4A41-A2EA-98D2539443FC Q33401619-5946504F-5AE4-483E-BA73-11CB46C9B9F5 Q33402372-6361A864-2CF1-4CA1-B752-A68B1BC92A5C Q33402784-E32AFEBC-165A-4B41-A587-E6DFA3317D21 Q33403172-9DCA42BF-B8B4-4BBE-84A8-AFD228B68AEB Q33403359-B446E378-C145-4106-B1B7-996C6960CB4E Q33404640-67924E64-ACA9-4D0B-B587-9D0F95CFEAE0 Q33404847-C145754C-4B02-40E5-9BD1-F76E607AB3DD

P2860

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

http://www.wikidata.org/entity/Q33385474

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@ast

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@en

type

label

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@ast

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@en

prefLabel

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@ast

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@en

P1433

Q33385474-74E00E8E-4C1A-4B8B-9EE9-771D237517A5

P1476

Q33385474-15A6FCCC-09DA-4817-8DAF-C6596535E580

P2093

Q33385474-0AD9AD30-E6AC-4778-9717-B59EEEA37F54

Q33385474-622D81BC-82B0-4275-AC1F-BFFE2F86AB08

Q33385474-850CDAFF-F419-4353-B39F-43B626F50D10

Q33385474-8C55AB4F-04E3-4838-9AC5-CED9C2482FE7

Q33385474-AC013026-FBA4-47D4-B245-7B90EAC82B93

Q33385474-B4863E7D-6F77-4850-8375-DFBCD0B7EBAE

Q33385474-CD7840A7-9AD1-4F77-B9CB-9AD3465BEEB1

Q33385474-D82A0D1F-AE9F-4738-B5BF-F9B887833D6C

Q33385474-FE5066C2-A618-4DAF-97A0-76B52B1745E7

P2860

Q33385474-04374B64-7E91-4136-BF13-6987F8EAB9AF

Q33385474-103A74CA-6BFB-4EA3-B563-626DC87CF22C

Q33385474-13837989-0E07-4E3B-8FFE-375FDFCC5440

Q33385474-1B0233C2-0BD4-4385-A8E5-B25277B711A6

Q33385474-2357A438-C3CF-4783-82A8-BB04C61A75BC

Q33385474-24027D33-B612-4519-9533-07FF88460CD1

Q33385474-26006E14-EC48-4A69-81ED-9F2A4C66D3BF

Q33385474-2666779E-907F-44D2-8ED0-DF9B20BB8D12

Q33385474-2CD6D20F-0FDA-4975-AFCB-D39D7ADECEFA

Q33385474-2DF5796E-D0AF-4748-9B6B-3469DA9E634A

P304

Q33385474-6C40C3B3-4258-481F-924F-E5BF94DDAD50

P31

Q33385474-7D77BE41-A244-4F20-A5FC-B8C1C08A1EEB

P356

Q33385474-0B64B5E3-D866-4A79-8523-FA67067F909B

P407

Q33385474-7AA7E268-626A-4A9B-A3F8-EF73D4B80D3C

P433

Q33385474-4A73AD0F-FF5F-4F16-AE60-982096F358E0

P478

Q33385474-B4155C32-3E8B-47E1-89C6-B33BFDB3492E

P50

Q33385474-427807A7-AE0D-4830-866F-EBD756665116

Q33385474-4C2E512D-AF47-40FB-A8BB-A4752D83E939

Q33385474-67E519D9-EF7E-4A02-9EDC-0FC2A086DEA5

Q33385474-719E6AAA-D32C-4B98-85C8-46494539A5A6

P577

Q33385474-CCAC7195-77A6-43B8-B0EF-E484E1B08D28

P698

Q33385474-B50BA6F7-8DA3-47C1-8AAF-E5D038E7AAA9

P932

Q33385474-F79D800F-29EE-460E-8C04-FF859BF74EF1

P356

P1433

The New England Journal of Medicine

P1476

Thrombomodulin mutations in atypical hemolytic-uremic syndrome.

@en

P2093

Astrid De Vriese

http://www.w3.org/2001/XMLSchema#string

Bart Claes

http://www.w3.org/2001/XMLSchema#string

Carla Zoja

http://www.w3.org/2001/XMLSchema#string

Charles T Esmon

http://www.w3.org/2001/XMLSchema#string

Gary Ferrell

http://www.w3.org/2001/XMLSchema#string

Jurgen Del-Favero

http://www.w3.org/2001/XMLSchema#string

Marina Noris

http://www.w3.org/2001/XMLSchema#string

Mieke Delvaeye

http://www.w3.org/2001/XMLSchema#string

Naomi L Esmon

http://www.w3.org/2001/XMLSchema#string

P2860

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Identification of the predominant glycosaminoglycan-attachment site in soluble recombinant human thrombomodulin: potential regulation of functionality by glycosyltransferase competition for serine474

A targeted point mutation in thrombomodulin generates viable mice with a prethrombotic state

Pathogenesis of thrombotic microangiopathies

Genetics of HUS: the impact of MCP, CFH, and IF mutations on clinical presentation, response to treatment, and outcome

Thrombomodulin-protein C-EPCR system: integrated to regulate coagulation and inflammation

Role of membrane cofactor protein (CD46) in regulation of C4b and C3b deposited on cells

Efficacy and safety of recombinant human activated protein C for severe sepsis

Discovery and identification of sequence polymorphisms and mutations with MALDI-TOF MS.

P304

345-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0810739

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

361

http://www.w3.org/2001/XMLSchema#string

P50

Giuseppe Remuzzi

Diether Lambrechts

Edward M. Conway

Stephane Plaisance

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19625716

http://www.w3.org/2001/XMLSchema#string

P932

3530919

http://www.w3.org/2001/XMLSchema#string